<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ymj</journal-id><journal-title-group><journal-title xml:lang="ru">Якутский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Yakut Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-1905</issn><issn pub-type="epub">2312-1017</issn><publisher><publisher-name>ЯНЦ КМП</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25789/YMJ.2026.94.04</article-id><article-id custom-type="elpub" pub-id-type="custom">ymj-3315</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Динамика и прогностическая ценность маркеров воспаления у больных с тяжелой внебольничной пневмонией</article-title><trans-title-group xml:lang="en"><trans-title>Dynamics and prognostic value of inflammatory markers in patients with severe community‑acquired pneumonia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-5356-2950</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чулакова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chulakova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чулакова Надежда Александровна – канд. мед. наук, доц. кафедры анестезиологии, реаниматологии и интенсивной терапии с курсом скорой медицинской помощи факультета последипломного обучения врачей ФГАОУ ВО «СВФУ им. М.К. Аммосова»; врач-анестезиолог-реаниматолог отделения анестезиологии, реанимации и интенсивной терапии (неврологическое) кардиососудистого центра ГАУ РС(Я) «РБ № 1 – НЦМ им. М.Е. Николаева».</p><p>ул. Ойунского, д. 27, Якутск, 677000; Сергеляхское ш., д. 4, Якутск, 677010</p></bio><email xlink:type="simple">chulakovan@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2087-543X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Потапов</surname><given-names>А. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Potapov</surname><given-names>A. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Потапов Александр Филиппович – д-р мед. наук, проф., проф. кафедры анестезиологии, реаниматологии и интенсивной терапии с курсом скорой медицинской помощи факультета последипломного обучения врачей.</p><p>ул. Ойунского, д. 27, Якутск, 677000</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-9084-0096</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Апросимов</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Aprosimov</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Апросимов Леонид Аркадьевич – канд. мед. наук, доц., зав. кафедрой анестезиологии, реаниматологии и интенсивной терапии с курсом скорой медицинской помощи факультета последипломного обучения врачей.</p><p>ул. Ойунского, д. 27, Якутск, 677000</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-6781-9550</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чулаков</surname><given-names>К. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Chulakov</surname><given-names>K. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чулаков Кирилл Викторович – врач-анестезиолог-реаниматолог отделения анестезиологии, реанимации и интенсивной терапии.</p><p>ул. Стадухина, д. 81 корп. 3, Якутск, 677000</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0002-6454-9230</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гайс</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gais</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гайс Сергей Викторович – ординатор 2 года обучения по специальности «Анестезиология-реаниматология».</p><p>ул. Ойунского, д. 27, Якутск, 677000</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ФГАОУ ВО «Северо-Восточный федеральный университет имени М.К. Аммосова»; ГАУ РС(Я) «Республиканская больница № 1 – Национальный центр медицины имени М.Е. Николаева»</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>ФГАОУ ВО «Северо-Восточный федеральный университет имени М.К. Аммосова»</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-3"><institution>ГБУ РС(Я) «Якутская республиканская клиническая больница»</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>21</day><month>06</month><year>2026</year></pub-date><volume>0</volume><issue>2</issue><fpage>18</fpage><lpage>23</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чулакова Н.А., Потапов А.Ф., Апросимов Л.А., Чулаков К.В., Гайс С.В., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Чулакова Н.А., Потапов А.Ф., Апросимов Л.А., Чулаков К.В., Гайс С.В.</copyright-holder><copyright-holder xml:lang="en">Chulakova N.A., Potapov A.F., Aprosimov L.A., Chulakov K.V., Gais S.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ymj.elpub.ru/jour/article/view/3315">https://ymj.elpub.ru/jour/article/view/3315</self-uri><abstract><p>В статье проводится изучение динамики лабораторных показателей воспалительного процесса у пациентов с тяжелой внебольничной пневмонией (ТВП) и оценивание их прогностической значимости в качестве маркеров летального исхода. Исследованы 50 пациентов с ТВП, поступивших в отделение анестезиологии, реанимации и интенсивной терапии (ОАРИТ) ГБУ Республики Саха (Якутия) «Якутская республиканская клиническая больница» за период с 01.08.2024 г. по 16.02.2025 г. В группах выживших и умерших исследованы лабораторные показатели в динамике за первые 5 сут госпитализации, а также проведен анализ расчетных гематологических индексов: нейтрофильно-лимфоцитарный индекс (НЛИ), дельта-нейтрофильный индекс (ДНИ), соотношение С-реактивного белка к альбумину. В результате тромбоцитопения нарастает в группе умерших к 3-м сут (р=0,039), уровень прокальцитонина с 4-х суток (р=0,044), гипоальбуминемия к 5-м сут (р=0,01). По данным ROC-анализа в качестве маркеров летального исхода у больных с ТВП среднюю прогностическую ценность имеют показатель ферритина в 1-е сут (AUC 0,711±0,088, р=0,022) и уровень тромбоцитов в 5-е сут (AUC 0,727±0,089, р=0,031).</p></abstract><trans-abstract xml:lang="en"><p>The article demonstrates dynamics of inflammatory laboratory tests in patients with severe community-acquired pneumonia (sCAP) and evaluates their prognostic value as mortality predictors. Fifty patients with sCAP admitted to the Anesthesiology and Intensive Care Unit (AICU) of the State Budgetary Institution of the Republic of Sakha (Yakutia) "Yakut Republican Clinical Hospital" in the period from 01.08.2024 to 16.02.2025 were examined. In the groups of survivors and deceased, laboratory tests were studied over time for the first 5 days of treatment, as well as an analysis of estimated hematological indices was carried out: neutrophil-lymphocyte index (NLI), delta-neutrophil index (DNI), C-reactive protein to albumin ratio. As a result, thrombocytopenia increased in the deceased group by day 3 (p=0,039), procalcitonin level from day 4 (p=0,044), hypoalbuminemia by day 5 (p=0,01). According to ROC analysis, ferritin on day 1 (AUC 0,711 ± 0,088, p = 0,022) and platelet count on day 5 (AUC 0,727±0,089, p=0,031) are of average prognostic value as markers of death in patients with PVI.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>тяжелая внебольничная пневмония</kwd><kwd>сепсис</kwd><kwd>лабораторные маркеры воспаления</kwd><kwd>прогнозирование летального исхода</kwd></kwd-group><kwd-group xml:lang="en"><kwd>severe community-acquired pneumonia</kwd><kwd>sepsis</kwd><kwd>inflammatory laboratory tests</kwd><kwd>mortality predictors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Авдеев С.Н., Дехнич А.В., Зайцев А.А., и др. Внебольничная пневмония у взрослых. Клинические рекомендации 2024 (краткая версия). Респираторная медицина. 2025;1(3):6-18. https://doi.org/10.17116/respmed202510316.</mixed-citation><mixed-citation xml:lang="en">Avdeev SN, Dekhnich AV, Zaytsev AA, et al. Community-acquired pneumonia in adults. Clinical guidelines 2024 (short version). Journal of Respiratory Medicine. 2025;1(3):6-18 (In Russian) https://doi.org/10.17116/respmed202510316.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Авдеев С.Н., Белобородов В.Б., Белоцерковский Б.З., и др. Тяжелая внебольничная пневмония у взрослых. Клинические рекомендации Федерации анестезиологов и реаниматологов России. Анестезиология и реаниматология. 2022;(1):6-35. https://doi.org/10.17116/anaesthesiology20220116.</mixed-citation><mixed-citation xml:lang="en">Avdeev SN, Beloborodov VB, Belotserkovskiy BZ, et al. Severe community-acquired pneumonia in adults. Clinical recommendations from Russian Federation of Anaesthesiologists and Reanimatologists. Russian Journal of Anesthesiology and Reanimatology. 2022; (1):6-35 (In Russian). https://doi.org/10.17116/anaesthesiology20220116.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Martin-Loeches I, Torres A, Nagavci B. et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. 2023; 49(6): 615-632. doi:10.1007/s00134-023-07033-8. Epub 2023 Apr 4. PMID: 37012484. PMCID: PMC10069946.</mixed-citation><mixed-citation xml:lang="en">Martin-Loeches I, Torres A, Nagavci B. et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. 2023; 49(6): 615-632. doi:10.1007/s00134-023-07033-8. Epub 2023 Apr 4. PMID: 37012484. PMCID: PMC10069946.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dequin PF, Torres A, Bassetti M, et al. Severe community-acquired pneumonia: current concepts and controversies. Intensive Care Med. 2026; 52(1): 118-130. doi:10.1007/s00134-025-08252-x. Epub 2026 Jan 12. PMID: 41524797. PMCID: PMC12852277.</mixed-citation><mixed-citation xml:lang="en">Dequin PF, Torres A, Bassetti M, et al. Severe community-acquired pneumonia: current concepts and controversies. Intensive Care Med. 2026; 52(1): 118-130. doi:10.1007/s00134-025-08252-x. Epub 2026 Jan 12. PMID: 41524797. PMCID: PMC12852277.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Park B.H., Kang Y.A., Park M.S. et al. Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis. BMC Infect Dis. 2011; 11(299). doi:10.1186/1471-2334-11-299. PMID: 22040292. PMCID: PMC3213213.</mixed-citation><mixed-citation xml:lang="en">Park B.H., Kang Y.A., Park M.S. et al. Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis. BMC Infect Dis. 2011; 11(299). doi:10.1186/1471-2334-11-299. PMID: 22040292. PMCID: PMC3213213.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Baran B., Yetkin N.A., Rabahoğlu В. et al. Assessment of Mortality Risk in Patients With Community-Acquired Pneumonia: Role of Novel Inflammatory Biomarkers. J Clin Lab Anal. 2025; 39(17):e70081. doi: 10.1002/jcla.70081. Epub 2025 Aug 13. PMID: 40801806; PMCID: PMC12423772.</mixed-citation><mixed-citation xml:lang="en">Baran B., Yetkin N.A., Rabahoğlu В. et al. Assessment of Mortality Risk in Patients With Community-Acquired Pneumonia: Role of Novel Inflammatory Biomarkers. J Clin Lab Anal. 2025; 39(17):e70081. doi: 10.1002/jcla.70081. Epub 2025 Aug 13. PMID: 40801806; PMCID: PMC12423772.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Кулабухов В.В., Шабанов А.К., Андреева И.В. и др. Биомаркеры инфекции в оптимизации антибактериальной терапии: оправданные ожидания. Клиническая микробиология и антимикробная химиотерапия. 2020; 22(3):175-187. https://doi.org/10.36488/cmac.2020.3.175-187</mixed-citation><mixed-citation xml:lang="en">Kulabukhov V., Shabanov A., Andreeva I. et al. Biomarkers of infection in the optimization of antibacterial therapy: justified expectations. Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(3):175-187 (In Russian). https://doi.org/10.36488/cmac.2020.3.175-187.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Руднов, В. А. Кулабухов В.В. Сепсис и терагностика. На пути к персонализированной медицине. Вестник анестезиологии и реаниматологии. 2015;12(6):60-67. https://doi.org/10.21292/2078-5658-2015-12-6-60-67</mixed-citation><mixed-citation xml:lang="en">Rudnov V.A., Kulabukhov V.V. Sepsis and teragnostics. on the way to personified medicine. Messenger of anesthesiology and resuscitation. 2015; 12(6): 60-67 (In Russian). https://doi.org/10.21292/2078-5658-2015-12-6-60-67.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">von Elm E., Altman D. G., Egger M. et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007; 335(7624): 806-808. doi:10.1136/bmj.39335.541782. PMID: 17947786. PMCID: PMC: 2034723.</mixed-citation><mixed-citation xml:lang="en">von Elm E., Altman D. G., Egger M. et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007; 335(7624): 806-808. doi:10.1136/bmj.39335.541782. PMID: 17947786. PMCID: PMC: 2034723.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Qiu X., Lei Y.P., Zhou R.X. SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2023; 21(8): 891-900. doi:10.1080/14787210.2023.2237192. Epub 2023 Jul 18. PMID 37450490.</mixed-citation><mixed-citation xml:lang="en">Qiu X., Lei Y.P., Zhou R.X. SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2023; 21(8): 891-900. doi:10.1080/14787210.2023.2237192. Epub 2023 Jul 18. PMID 37450490.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou H, Lan T, Guo S. Prognostic Prediction Value of qSOFA, SOFA, and Admission Lactate in Septic Patients with Community-Acquired Pneumonia in Emergency Department. Emerg Med Int. 2020; 7979353. doi:10.1155/2020/7979353. PMID: 32322422; PMCID: PMC7165341.</mixed-citation><mixed-citation xml:lang="en">Zhou H, Lan T, Guo S. Prognostic Prediction Value of qSOFA, SOFA, and Admission Lactate in Septic Patients with Community-Acquired Pneumonia in Emergency Department. Emerg Med Int. 2020; 7979353. doi:10.1155/2020/7979353. PMID: 32322422; PMCID: PMC7165341.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Багненко С.Ф., Горобец Е.С., Гусаров В.Г. и др. Клинические рекомендации «Сепсис (у взрослых)». Вестник анестезиологии и реаниматологии. 2025; 22(1): 80-109. https://doi.org/10.24884/2078-5658-2025-22-1-81-109</mixed-citation><mixed-citation xml:lang="en">Bagnenko S.F., Gorobets E.S., Gusarov V.G. t al. Clinical guidelines «Sepsis (in adults)». Messenger of anesthesiology and resuscitation. 2025;22(1):80-109 (In Russian). https://doi.org/10.24884/2078-5658-2025-22-1-81-109.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Liao Y, Zeng T, Guo X, Li X. Ferritin’s role in infectious diseases: Exploring pathogenic mechanisms and clinical implications. New Microbes New Infect. 2025; 65:101582. Published 2025 Mar 20. doi: 10.1016/j.nmni.2025.101582. PMID: 40230813; PMCID: PMC11995792.</mixed-citation><mixed-citation xml:lang="en">Liao Y, Zeng T, Guo X, Li X. Ferritin’s role in infectious diseases: Exploring pathogenic mechanisms and clinical implications. New Microbes New Infect. 2025; 65:101582. Published 2025 Mar 20. doi: 10.1016/j.nmni.2025.101582. PMID: 40230813; PMCID: PMC11995792.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fang Y.P., Zhang H.J., Guo Z. et al. Effect of Serum Ferritin on the Prognosis of Patients with Sepsis: Data from the MIMIC-IV Database. Emerg Med Int. 2022. 2022(2104755). Published 2022 Dec 6. doi:10.1155/2022/2104755. PMID: 36523541; PMCID: PMC9747303.</mixed-citation><mixed-citation xml:lang="en">Fang Y.P., Zhang H.J., Guo Z. et al. Effect of Serum Ferritin on the Prognosis of Patients with Sepsis: Data from the MIMIC-IV Database. Emerg Med Int. 2022. 2022(2104755). Published 2022 Dec 6. doi:10.1155/2022/2104755. PMID: 36523541; PMCID: PMC9747303.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
